- cafead Aug 23, 2023 at 06:02: PM
via Rapport Therapeutics brought in $150 million in funds in a Series B round, the company announced Wednesday.
Investors include Fidelity Management & Research Company, Goldman Sachs Asset Management, Logos Capital as well as Johnson & Johnson Innovation, among others.
article source
Investors include Fidelity Management & Research Company, Goldman Sachs Asset Management, Logos Capital as well as Johnson & Johnson Innovation, among others.
article source